SenesTech Inc
$ 1.78
0.00%
12 Feb - close price
- Market Cap 9,297,000 USD
- Current Price $ 1.78
- High / Low $ 1.79 / 1.66
- Stock P/E N/A
- Book Value 2.17
- EPS -2.21
- Next Earning Report 2026-03-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.38 %
- ROE -0.78 %
- 52 Week High 6.24
- 52 Week Low 1.30
About
SenesTech, Inc. develops a technology for managing animal pest populations by controlling fertility. The company is headquartered in Phoenix, Arizona.
Analyst Target Price
$10.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-11 | 2025-08-08 | 2025-05-07 | 2025-03-12 | 2024-11-12 | 2024-08-08 | 2024-05-09 | 2024-02-21 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-16 |
| Reported EPS | -0.28 | -0.87 | -1.2808 | -1.22 | -2.07 | -3.08 | -0.36 | -0.9 | -0.47 | -0.7 | -1.32 | -3.21 |
| Estimated EPS | -0.35 | None | None | -1.5 | -3.2 | -3.2 | -0.34 | -0.44 | -0.85 | -0.78 | -0.81 | -4.2 |
| Surprise | 0.07 | 0 | 0 | 0.28 | 1.13 | 0.12 | -0.02 | -0.46 | 0.38 | 0.08 | -0.51 | 0.99 |
| Surprise Percentage | 20% | None% | None% | 18.6667% | 35.3125% | 3.75% | -5.8824% | -104.5455% | 44.7059% | 10.2564% | -62.963% | 23.5714% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-11 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.3 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SNES
2026-02-11 07:58:30
SenesTech, Inc. (NASDAQ:SNES) announced it will directly manage Amazon sales of its Evolve Rat and Evolve Mouse products, effective immediately. This strategic change aims to enhance e-commerce operations, which represented over 50% of the company's 2025 revenue. By taking control of product presentation and customer communication, SenesTech expects to retain a larger portion of e-commerce revenue, with financial benefits anticipated to grow significantly in Q2 2026.
2026-02-10 08:00:00
SenesTech, Inc. announced it will directly manage the sales of its Evolve™ Rat and Evolve™ Mouse products on Amazon, shifting from third-party management. This change is effective immediately and aims to increase revenue and enhance profit margins on their e-commerce channel. The company expects greater control over product presentation and customer engagement, leveraging internal resources to optimize sales and marketing efforts.
2026-02-07 18:03:11
Glenbrook Capital Management, a significant owner of SenesTech, Inc. (NASDAQ:SNES), recently increased its stake by purchasing 8,569 shares across two transactions totaling $15,479. This raises their total holdings to 602,354 shares. The increased investment follows SenesTech's strong Q3 2025 revenue growth and the approval of its rodent birth control product in New Zealand, alongside the upcoming retirement of CEO Joel Fruendt.
2026-02-06 22:29:21
Glenbrook Capital Management, a significant shareholder in SenesTech, Inc. (SNES), recently acquired an additional 8,569 shares for a total of $15,479 across two transactions on February 4th and 5th, 2026. This purchase increases their total holding to 602,354 shares. The company has also seen a 43% revenue increase in Q3 2025, approval for its Evolve product in New Zealand, and announced the retirement of CEO Joel Fruendt.
2026-02-03 06:59:15
SenesTech's Evolve®, a non-lethal rodent birth control solution, has been approved for use in New Zealand. This approval supports New Zealand's Predator Free 2050 initiative, which aims to eradicate invasive predators to protect native wildlife. SenesTech's distribution partner, Evicom, has already received its initial stocking order, with regular shipments expected to continue.
2026-02-03 01:28:56
SenesTech's Evolve rodent fertility control solution has been approved for use in New Zealand by the Ministry for Primary Industries, and the company has shipped an initial stocking order to its distributor Evicom. This non-lethal product supports New Zealand's Predator Free 2050 initiative, aiming to manage rodent populations by restricting reproduction. Despite a stock decline, SenesTech reported strong revenue growth, with its CEO Joel Fruendt set to retire after overseeing the product's launch and expansion.
